← Open Payments lookup

CALISTA KU: Open Payments

NPI 1982122750 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$469 in 12 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $217 · 2025 $469

Food & beverage: $439Long term medical supply or device loan: $30
CompanyPaymentsAmount
Novo Nordisk Inc3$165
Dexcom, Inc.2$117
Abbott Laboratories2$53
Bayer Healthcare Pharmaceuticals Inc.1$35
Edwards Lifesciences Corporation1$29
Amgen Inc.1$25
Tandem Diabetes Care, Inc.1$24
Lilly USA, LLC1$22

Products named: Ozempic, Dexcom G6 Transmitter, Kerendia, FREESTYLE INSULINX, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), EVENITY, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3.

Industry payments across WA — which companies pay providers there.